Trump says his HCQ regimen finishes soon

May 21, 2020 11:32

US President Donald Trump has said that the regimen of antimalarial drug hydroxychloroquine that he is taking to ward off the coronavirus will finish in the next day or two. Trump disclosed on Tuesday that he was taking the drug despite medical warnings about potential serious side effects and questions about its effectiveness in preventing the coronavirus.

"I think the regimen finishes in a day or two," Trump told reporters at the White House on Wednesday when asked how long he will continue to take the antimalarial drug. White House Press Secretary Kayleigh McEnany defended the president's taking of the drug as a preventive measure against the coronavirus pandemic.

"Hydroxychloroquine has been a drug that has been in use for 65 years for lupus, arthritis, and malaria. It has a very good safety profile. But as with any drug and as with any prescription, it should be given by a doctor to a patient in that context. So no one should be taking this without a prescription from their doctor," she said. -- PTI

« Back to LIVE

TOP STORIES

So That's Why Sharvari, Vaani Are Looking So Pretty

Are these B-Town's most fashionable floral moments?

Control the controllables: Patidar's mantra for success against SRH

Rajat Patidar struck a quickfire half-century to set up Royal Challengers Bengaluru for a 35-run win over Sunrisers Hyderabad in their IPL match at the Rajiv Gandhi International Stadium on Thursday.

2nd phase of LS poll underway amid heat wave concerns

The IMD has warned of heatwave to severe heatwave conditions in parts of West Bengal, Odisha, Bihar, Jharkhand, Andhra Pradesh, Telangana, Karnataka and Uttar Pradesh during the next five days.

'Modi's Speech Is A Response To Congress Obsession With Vote Bank Politics'

'You want to distort the very fabric of Indian society because you are obsessed with vote bank politics.'

Get Ready For More Romance On OTT!

From Vijay Devarakonda to Kung Fu Panda, Sukanya Verma lists everything you can watch on OTT this week.